Vridapa 5 Tablet
Marketer
Vridam Healthcare Pvt Ltd
Salt Composition
Dapagliflozin (5mg)
Overview Vridapa 5 Tablet
Metformin 5 mg tablets are prescribed for managing type 2 diabetes, either independently or alongside other medications. Their function is to regulate elevated blood glucose, thereby lessening the likelihood of severe diabetic complications and contributing to heart health prevention. This medication can be ingested with or without food, but consistent daily timing is recommended; dosage is determined by your physician. Discontinuation requires medical consultation, as abrupt cessation could elevate blood sugar, risking serious consequences such as renal impairment and vision loss. This medication complements a comprehensive treatment plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Commonly reported side effects include vaginal yeast infections, upper respiratory infections (affecting the throat and nasal passages), and urinary tract infections; it may also induce fluid loss, necessitating increased fluid intake to avoid dehydration. Practicing good hygiene can mitigate the risk of genital fungal infections. Prior to initiating treatment, inform your doctor of any pre-existing kidney or liver conditions, urinary tract infections, or diuretic use. Pregnant or lactating individuals should seek medical advice before use. Limit alcohol consumption during treatment to minimize potential side effect exacerbation. Regular blood glucose monitoring is crucial during therapy.
Uses of Vridapa 5 Tablet
Managing type 2 diabetes
Major Benefits of Vridapa 5 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Vridapa 5 Tablet whole; do not crush, chew, or break it. This medication can be taken with or without food, although consistent timing is recommended.
Common Side effects of Vridapa 5 Tablet:
- Polyuria
- Nausea
- Vomiting
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
How to use Vridapa 5 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Vridapa 5 Tablet whole; avoid chewing, crushing, or breaking it. While it can be taken with or without food, consistency is key – take it at the same time each day.
How Vridapa 5 Tablet works:
Vridapa 5 tablets help manage diabetes by promoting the excretion of excess glucose via the kidneys.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol while taking Vridapa 5 Tablet.
PregnancyCONSULT YOUR DOCTOR
Using Vridapa 5 Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Nursing mothers should likely avoid Vridapa 5 Tablet. Studies in humans indicate a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Vridapa 5 Tablet is likely inadvisable for individuals with kidney impairment and should be forgone. Medical advice is recommended.
LiverSAFE IF PRESCRIBED
Vridapa 5 Tablet poses no safety concerns for patients with hepatic impairment. No modification of the Vridapa 5 Tablet dosage is necessary.
What if you forget to take Vridapa 5 Tablet :
Should you forget to take a Vridapa 5 Tablet, ingest it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosage regimen. Avoid taking a double dose.
Facts to Know About Vridapa 5 Tablet
| Label | Value |
|---|---|
| Chemical Type | Phenolic Glycoside Derivative |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Actions | Sodium-glucose cotransporter 2 (SGLT2) inhibitors |





